chr10-94775367-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000769.4(CYP2C19):c.332-23A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.165 in 1,612,890 control chromosomes in the GnomAD database, including 24,492 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★★). There are indicators that this mutation may affect the branch point..
Frequency
Genomes: 𝑓 0.17 ( 2548 hom., cov: 32)
Exomes 𝑓: 0.16 ( 21944 hom. )
Consequence
CYP2C19
NM_000769.4 intron
NM_000769.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.34
Genes affected
CYP2C19 (HGNC:2621): (cytochrome P450 family 2 subfamily C member 19) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
This place is a probable branch point but rather VUS (scored 5 / 10). Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP2C19 | NM_000769.4 | c.332-23A>G | intron_variant | ENST00000371321.9 | NP_000760.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2C19 | ENST00000371321.9 | c.332-23A>G | intron_variant | 1 | NM_000769.4 | ENSP00000360372 | P1 | |||
CYP2C19 | ENST00000480405.2 | c.332-23A>G | intron_variant | 1 | ENSP00000483847 | |||||
CYP2C19 | ENST00000645461.1 | n.1385-23A>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.173 AC: 26303AN: 151746Hom.: 2543 Cov.: 32
GnomAD3 genomes
AF:
AC:
26303
AN:
151746
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.180 AC: 45341AN: 251244Hom.: 4851 AF XY: 0.187 AC XY: 25439AN XY: 135780
GnomAD3 exomes
AF:
AC:
45341
AN:
251244
Hom.:
AF XY:
AC XY:
25439
AN XY:
135780
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.164 AC: 239816AN: 1461026Hom.: 21944 Cov.: 33 AF XY: 0.169 AC XY: 122657AN XY: 726806
GnomAD4 exome
AF:
AC:
239816
AN:
1461026
Hom.:
Cov.:
33
AF XY:
AC XY:
122657
AN XY:
726806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.173 AC: 26324AN: 151864Hom.: 2548 Cov.: 32 AF XY: 0.177 AC XY: 13157AN XY: 74166
GnomAD4 genome
AF:
AC:
26324
AN:
151864
Hom.:
Cov.:
32
AF XY:
AC XY:
13157
AN XY:
74166
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1059
AN:
3478
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: practice guideline
LINK: link
Submissions by phenotype
CYP2C19: no function Other:1
drug response, practice guideline | curation | Clinical Pharmacogenetics Implementation Consortium | - | - Allele function |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
La Branchor
BranchPoint Hunter
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at